Activating mTOR Mutations Are Detrimental in Nutrient-Poor Conditions

Area of Science:

• Cellular biology
• Oncology
• Molecular signaling

Background:

• The mechanistic target of rapamycin (mTOR) pathway regulates cell growth and is crucial for integrating nutrient and growth factor signals.
• Activating mutations in mTOR are predicted to promote tumor growth, yet are rarely observed in most cancer types, with enrichment primarily in renal clear cell carcinoma.

Purpose of the Study:

• To investigate the cancer-type-specific restriction of activating mTOR mutations.
• To understand the role of mTOR signaling in nutrient stress adaptation in cancer cells.

Main Methods:

• Studied the effects of activating mTOR mutations on cell growth and survival under varying nutrient conditions.
• Analyzed existing tumor sequencing data to assess the prevalence and phenotype of oncogenic mutations in the mTOR pathway.

Main Results:

• Activating mTOR mutants promoted cell growth independently of nutrient availability but compromised cell survival under nutrient-poor conditions.
• Oncogenic mutations in the nutrient-sensing arm of the mTOR pathway exhibited similar nutrient-dependent phenotypes and were rare across human cancers.

Conclusions:

• The ability to inactivate mTOR signaling in response to nutrient stress is essential for cell survival and is maintained in most naturally occurring tumors.
• This explains the rarity of activating mTOR mutations and the limited efficacy of mTOR inhibitors in many cancer types.